Tfh cells with NLRP3 inflammasome activation are essential for high-affinity antibody generation, germinal centre formation and autoimmunity
- 12 April 2022
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (7), 1006-1012
- https://doi.org/10.1136/annrheumdis-2021-221985
Abstract
Objective NLRP3 inflammasome regulates T cell responses. This study examined the roles of NLRP3 inflammasome activation in the regulation of T follicular helper (Tfh) cells during humoral response to T dependent antigens and in systemic lupus erythematosus (SLE). Methods NLRP3 inflammasome activation of Tfh cells was studied in B6, MRL/lpr and NZM2328 mice and in SLE patients and healthy controls using a fluorescence-labelled caspase-1 inhibitor probe. MCC950, a selective inhibitor of NLRP3, was used to investigate the relation between NLRP3 inflammasome activation and germinal centre (GC) reaction, Ab responses to immunisation, and autoantibody production. Results NLRP3 inflammasome activation in Tfh cells after immunisation was identified in B6 mice. MCC950 inhibited humoral responses to sheep red blood cell and NP-CGG with reduction of the GC reaction. B6 mice with lymphoid cell-specific deletion of NLRP3 or Casp1 mounted suboptimal humoral responses with impaired GC formation and defective affinity maturation. In MRL/lpr and NZM2328 mice, inhibition of NLRP3 activation suppressed NLRP3 activated Tfh cell expansion as well as attenuated lupus-like phenotypes. Tfh cells with activated NLRP3 inflammasome exhibited increased expression of molecules for Tfh cell function and differentiation, and had greater ability to activate B cells. In SLE patients, disease activity was positively correlated with an increase in the activated NLRP3+ Tfh population and this population was markedly reduced in response to therapy. Conclusions The activation of NLRP3 inflammasome in Tfh cells is an integral part of responses to immunisation. The activated NLRP3+ Tfh population is essential for optimal humoral responses, GC formation and autoimmunity.Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR047988)
- National Natural Science Foundation of China (81671593, 81701595, 81971519, 82171770)
- Alliance for Lupus Research (TIL332635)
- Natural Science Foundation of Guangdong Province (2021A1515012072)
- National Institute of Allergy and Infectious Diseases (R01 AI148231)
This publication has 30 references indexed in Scilit:
- Dysregulation of germinal centres in autoimmune diseaseNature Reviews Immunology, 2009
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiationProceedings of the National Academy of Sciences of the United States of America, 2009
- Follicular helper T cells are required for systemic autoimmunityThe Journal of Experimental Medicine, 2009
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Interleukin-1 Contributes to High Level IgG Production in the Murine MRL/Ipr Lupus ModelImmunological Investigations, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.The Journal of Experimental Medicine, 1988
- Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.The Journal of Experimental Medicine, 1988
- Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells.The Journal of Experimental Medicine, 1987